Invention Grant
- Patent Title: Endoluminal device for in vivo delivery of bioactive agents
- Patent Title (中): 用于体内递送生物活性剂的腔内装置
-
Application No.: US13412407Application Date: 2012-03-05
-
Publication No.: US08697175B2Publication Date: 2014-04-15
- Inventor: Christopher T. Boyle
- Applicant: Christopher T. Boyle
- Applicant Address: US TX Dallas
- Assignee: Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc.
- Current Assignee: Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc.
- Current Assignee Address: US TX Dallas
- Agency: Rosenbaum IP
- Agent David G. Rosenbaum; J. Peter Paredes
- Main IPC: A61L33/00
- IPC: A61L33/00

Abstract:
The present invention consists of an implantable structural element for in vivo delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Alternatively, the implantable structural element may simply be an implantable article that serves the single function of acting as a time-release carrier for the bioactive agent.
Public/Granted literature
- US20120221098A1 ENDOLUMINAL DEVICE FOR IN VIVO DELIVERY OF BIOACTIVE AGENTS Public/Granted day:2012-08-30
Information query